Concepedia

Publication | Closed Access

["Catastrophic systemic lupus erythematosus" with Rosai-Dorfman sinus histiocytosis. Successful treatment with anti-CD20/rutuximab].

DOI

43

Citations

0

References

2001

Year

F Petschner, U.A. Walker, M. Uhl, H H Peter
PubMed

Abstract

Sinus histiocytosis of Rosai/Dorfman can be associated with or mimic severe SLE. Rituximab, an anti-CD20 monoclonal antibody, may improve the antibody-mediated pathogenetic mechanism underlying both entities.